VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $35,769,000 | -40.1% | 1,539,100 | -59.0% | 0.20% | -37.7% |
| Q1 2018 | $59,736,000 | -49.8% | 3,752,238 | -34.5% | 0.32% | -42.5% |
| Q4 2017 | $119,038,000 | +610.0% | 5,728,500 | +389.6% | 0.56% | +407.3% |
| Q3 2017 | $16,767,000 | -33.6% | 1,170,045 | -19.9% | 0.11% | -34.9% |
| Q2 2017 | $25,264,000 | -63.9% | 1,460,357 | -77.0% | 0.17% | -67.6% |
| Q1 2017 | $69,998,000 | +89.0% | 6,346,130 | +148.8% | 0.52% | +150.5% |
| Q4 2016 | $37,043,000 | -3.3% | 2,551,174 | +63.5% | 0.21% | +5.1% |
| Q3 2016 | $38,318,000 | +9.8% | 1,560,797 | -9.9% | 0.20% | +24.5% |
| Q2 2016 | $34,898,000 | -41.1% | 1,732,747 | -23.1% | 0.16% | -53.4% |
| Q1 2016 | $59,247,000 | +45.5% | 2,252,744 | +462.2% | 0.34% | +47.6% |
| Q4 2015 | $40,728,000 | +381.8% | 400,674 | +745.6% | 0.23% | +371.4% |
| Q3 2015 | $8,454,000 | -36.7% | 47,386 | -21.2% | 0.05% | -29.0% |
| Q2 2015 | $13,366,000 | -70.0% | 60,165 | -73.2% | 0.07% | -72.4% |
| Q1 2015 | $44,608,000 | -78.6% | 224,538 | -84.6% | 0.25% | -79.5% |
| Q4 2014 | $208,131,000 | +42.4% | 1,454,337 | +30.5% | 1.22% | +22.3% |
| Q3 2014 | $146,192,000 | +39.2% | 1,114,267 | +33.8% | 1.00% | +12.5% |
| Q2 2014 | $105,045,000 | +11782.9% | 832,900 | +12322.1% | 0.89% | +9766.7% |
| Q1 2014 | $884,000 | -91.2% | 6,705 | -92.2% | 0.01% | -85.9% |
| Q4 2013 | $10,085,000 | +1071.3% | 85,900 | +759.0% | 0.06% | +611.1% |
| Q2 2013 | $861,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |